ReP USP - Resultado da busca

Artigo de periodico
Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models (2025)
Lima, Mauro Almeida ; Teixeira, Tamara ; Fortaleza, Dario Batista ; Pereira, George Bueno Santana ; Akinyemi, Amos Olalekan ; Moraes, Carlos André Ferreira ; Forim, Moacir Rossi ; Batista, Alzir Azevedo ; Dutra, Jocely de Lucena ; de Araujo Neto, João Honorato ; Ellena, Javier ; Rocha, Fillipe Vieira
Source: Pharmaceutics. Unidades: IQ, IFSC
Subjects: NEOPLASIAS OVARIANAS, ANTINEOPLÁSICOS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Mauro Almeida et al. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models. Pharmaceutics, v. 17, n. 7, p. 829-1-829-23 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17070829. Acesso em: 08 out. 2025.
APA
Lima, M. A., Teixeira, T., Fortaleza, D. B., Pereira, G. B. S., Akinyemi, A. O., Moraes, C. A. F., et al. (2025). Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models. Pharmaceutics, 17( 7), 829-1-829-23 + supplementary materials. doi:10.3390/pharmaceutics17070829
NLM
Lima MA, Teixeira T, Fortaleza DB, Pereira GBS, Akinyemi AO, Moraes CAF, Forim MR, Batista AA, Dutra J de L, de Araujo Neto JH, Ellena J, Rocha FV. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models [Internet]. Pharmaceutics. 2025 ; 17( 7): 829-1-829-23 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics17070829
Vancouver
Lima MA, Teixeira T, Fortaleza DB, Pereira GBS, Akinyemi AO, Moraes CAF, Forim MR, Batista AA, Dutra J de L, de Araujo Neto JH, Ellena J, Rocha FV. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models [Internet]. Pharmaceutics. 2025 ; 17( 7): 829-1-829-23 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics17070829
Artigo de periodico
Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein (2023)
Bitencourt, Natália Vitória ; Righetto, Gabriela Marinho; Camargo, Ilana Lopes Baratella da Cunha ; Godoy, Mariana Ortiz de ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Santos Filho, Norival Alves ; Cilli, Eduardo Maffud
Source: Pharmaceutics. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITENCOURT, Natália Vitória et al. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, v. 15, n. 2, p. 436-1-436-17 + supplementary materials: 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15020436. Acesso em: 08 out. 2025.
APA
Bitencourt, N. V., Righetto, G. M., Camargo, I. L. B. da C., Godoy, M. O. de, Guido, R. V. C., Oliva, G., et al. (2023). Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, 15( 2), 436-1-436-17 + supplementary materials: 1-8. doi:10.3390/pharmaceutics15020436
NLM
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Vancouver
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Artigo de periodico
Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents (2023)
Failache, Natalia Alvarez ; Costa, Analu Rocha ; Collazo, Victoria; Ellena, Javier ; Costa Filho, Antonio José da ; Batista, Alzir Azevedo ; Facchin, Gianella
Source: Pharmaceutics. Unidades: IFSC, FFCLRP
Subjects: CRISTALOGRAFIA, PLANEJAMENTO DE FÁRMACOS, NEOPLASIAS (TRATAMENTO), CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAILACHE, Natalia Alvarez et al. Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents. Pharmaceutics, v. 15, n. 5, p. 1345-1-1345-18 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051345. Acesso em: 08 out. 2025.
APA
Failache, N. A., Costa, A. R., Collazo, V., Ellena, J., Costa Filho, A. J. da, Batista, A. A., & Facchin, G. (2023). Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents. Pharmaceutics, 15( 5), 1345-1-1345-18 + supplementary materials. doi:10.3390/pharmaceutics15051345
NLM
Failache NA, Costa AR, Collazo V, Ellena J, Costa Filho AJ da, Batista AA, Facchin G. Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents [Internet]. Pharmaceutics. 2023 ; 15( 5): 1345-1-1345-18 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics15051345
Vancouver
Failache NA, Costa AR, Collazo V, Ellena J, Costa Filho AJ da, Batista AA, Facchin G. Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents [Internet]. Pharmaceutics. 2023 ; 15( 5): 1345-1-1345-18 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics15051345

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies